We have recently found evidence for this model with the observation that the 1100delC variant in CHEK2 which is carried by ∼1% of the population confers a 1.7-fold increased risk of breast cancer (Meijers-Heijboer et al, 2002). Here, CHEK2 is linked to breast cancer.